Mark A. Peppercorn

Statistics

Publications

Citations

5.4K

H-Index

Active since

1969

Affiliations

Beth Israel Deaconess Medical Center(Current)

Beth Israel Deaconess Hospital

Harvard University

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Mark A. Peppercorn is an author at Beth Israel Deaconess Medical Center specializing in inflammatory bowel disease, medicine, and gastrointestinal inflammation.

Publications per year

1969–2011

Publications

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial

Richard J. Farrell, Mazen Alsahli, Yoon‐Tae Jeen et al. · Gastroenterology · 2003 · 558 citations · Full text

Medicine, Clinical Sciences, Immunology +10

Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis

Alain Bitton, Mark A. Peppercorn, Donald A. Antonioli et al. · Gastroenterology · 2001 · 487 citations · Full text

Medicine, Immunology, Pathology +14

Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial

Stephen B. Hanauer, Burton I. Korelitz, Paul Rutgeerts et al. · Gastroenterology · 2004 · 468 citations

Pharmacy, Pharmacotherapy, Gastroenterology +13

THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE

Mark A. Peppercorn, Peter Goldman · Journal of Pharmacology and Experimental Therapeutics · 1972 · 441 citations

Life Sciences, Microbiology, Pharmacology +14

Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial

John W. Singleton, Stephen B. Hanauer, Gary Gitnick et al. · Gastroenterology · 1993 · 361 citations

Medicine, Clinical Sciences, Pharmacotherapy +8

1–5 of 49